Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

StatXFinder: a web-based self-directed tool that provides appropriate statistical test selection for biomedical researchers in their scientific studies.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Nutrients, Microglia Aging, and Brain Aging.
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Dimethyl fumarate for treating relapsing multiple sclerosis.
Neuroinflammation: Modulating mighty microglia.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective.
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise

Pages